NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 31, 2015--
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent
company of Lantheus Medical Imaging, Inc. (“LMI”), today announced that
Mary Anne Heino, President and Chief Executive Officer, and John
Bakewell, Chief Financial Officer, will participate in two upcoming
conferences. The sessions will include a corporate overview followed by
a question and answer discussion.
The sessions will take place as follows:
September 9, at 1:45 p.m. ET - Wells Fargo 2015 Healthcare Conference
in Boston; and
September 10, at 8:30 a.m. ET - Baird 2015 Healthcare Conference in
To access a live webcast of the discussions, please visit the Company’s
website at www.lantheus.com.
A replay of the webcasts will be available on the Company’s website for
30 days following the live discussions.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical
Imaging, Inc. (“LMI”), which is a global leader in developing,
manufacturing, selling and distributing innovative diagnostic imaging
agents and products. LMI provides a broad portfolio of products, which
are primarily used for the diagnosis of cardiovascular diseases. LMI’s
key products include the echocardiography contrast agent DEFINITY®
Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs.
The Company has more than 500 employees worldwide with headquarters in
North Billerica, Massachusetts, and offices in Puerto Rico, Canada and
Australia. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150831006120/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.